During computed tomography coronary angiography (CTCA) unexpected changes in heart rate while scanning may affect image quality. Purpose: To evaluate whether an iso-osmolar contrast medium (IOCM, iodixanol) and a lowosmolar contrast medium (LOCM, iomeprol) affect heart rate and experienced heat sensation differently. Material and Methods: One hundred patients scheduled for CTCA were randomized to receive either iodixanol 320 mgI/ml or iomeprol 400 mgI/ml. Depending on their heart rate, the patients were assigned to one of fi ve scanning protocols, each optimized for different heart rate ranges. During scanning the time between each heart beat (hb) was recorded, and the corresponding heart rate was calculated. For each contrast medium (CM) the average heart rate, the variation in heart rate from individual mean heart rate, and the mean deviation from the predefi ned scanning protocol were calculated. Experience of heat was obtained immediately after scanning by using a visual analog scale (VAS). Examination quality was rated by two radiologists on a three-point scale. Results: The mean variation in heart rate after IOCM was 1.4 hb/min and after LOCM it was 4.4 hb/min (NS). The mean deviations in heart rate from that in the predefi ned scanning protocol were 2.0 hb/min and 4.7 hb/min, respectively (NS). A greater number of arrhythmic hb were observed after LOCM compared with IOCM ( P Ͻ 0.001). There was no statistically signifi cant difference in image quality. The LOCM group reported a stronger heat sensation after CM injection than the IOCM group (VAS ϭ 36 mm and 18 mm, P Ͻ 0.05). Conclusion: At clinically used concentrations the IOCM, iodixanol 320 mgI/ml, does not increase the heart rate during CTCA and causes less heart arrhythmia and less heat sensation than the LOCM, iomeprol 400 mgI/ml.
The coronary arteries can be visualized at computed tomography coronary angiography (CTCA) by retrospective analysis of the data collected during the diastolic part of the heart cycle. Typically the period 70 -80% of the R-R interval is used for imaging. To reduce the total radiation exposure, the radiation dose is decreased during periods of the heart cycle when imaging is not optimal due to cardiac motion (1 -4) . Therefore to accurately optimize the scanning parameters, it is important to correctly predict the heart rate for the following scanning (5). Previous studies have shown that the heart rate and/or variations in heart rate during scanning can affect image quality ( Fig. 1) (6, 7). Adverse effects from contrast medium (CM), such as reduction of contractibility and vasodilatation, have been reported. These changes have been described as related to CM chemotoxicity, osmolality, and calciumbinding properties, and the concentration of sodium in . The use of non-ionic CM caused less adverse effects compared with those of ionic CM (14, 15) . A difference has also been shown in adverse effects between low-osmolar (LOCM) and iso-osmolar contrast media (IOCM) (16, 17) , but the effect of CM on heart rate and its infl uence on adherence to protocols used during CTCA has not been clarifi ed. The aim of this study was to evaluate heart rate variation and how it affects compliance with the imaging protocol at CTCA when using the IOCM, iodixanol, or the LOCM, iomeprol. The effect of heart rate variation on image quality and the frequency of experienced heat sensation were also studied.
Material and Methods

Study population
After approval by the local ethics committee, 100 patients (63 men and 37 women) aged 51 -85 years (mean 63 years) were included in the study. Inclusion criteria were patients scheduled for CTCA, aged 50 years or older, with a glomerular fi ltration rate (GFR) of at least 50 ml/min according to and without a history of renal disease.
Scanning technique
For all examinations a GE Light Speed VCT (GE Healthcare, Milwaukee, Wisc., USA) was used. It has a shortest rotation time of 0.35 s, 0.625 mm slice thickness, and a reconstruction interval of 0.625 mm with maximum detector coverage of 4 cm. The temporal resolution in retrospective mode and sampling reconstructed data from one R-R interval is 270 ms. Before scanning, the patients were asked to hold their breath after a few forced breaths to enable evaluation of individual endurance and heart rate during apnea. The monitored heart rate was recorded and used to select the appropriate scan protocol as suggested by the manufacturer (Table 1) .
CM injection technique
Patients were randomized to either the IOCM iodixanol 320 mg I/ml (Visipaque ® -320, GE Healthcare, Chalfont St Giles, UK) or the LOCM iomeprol 400 mgI/ml (Iomeron ® -400, Bracco Imaging SpA, Milan, Italy) by using sealed envelopes. The CM was injected through a 16-gauge peripheral venous catheter at 5 ml/s using an auto injector (Medrad, Stellant Dual Head Injector, Pittsburgh, Pa., USA). A triple-phase CM protocol was applied (50 ml pure CM followed by 50 ml mixture of CM and physiologic NaCl (40% CM and 60% NaCl), and fi nally 50 ml physiologic NaCl). A 40 ml test bolus of 50% CM and 50% physiologic NaCl was used to optimize the timing of the acquisitions. The fi nal delay time for the scanning was defi ned as the time for the highest attenuation of the ascending aorta plus 7 s delay to compensate for the larger amount of CM in the triple-phase protocol.
Acquisition of heart rate
During scanning the heart rate was automatically recorded using standard ECG leads. The heart rate for each heart beat (hb) was defi ned as 2 divided by the time that elapsed from the previous hb to the next hb (Fig. 2) . The equipment stored the heart rate obtained for each hb with the respective image and it was automatically written out on the displayed images at evaluation. To obtain the individual heart rate and its variation during scanning, the following method was used. The table position and displayed heart rate at the position 20 mm superior to the origin of the left anterior descending artery (LAD) were noted. The images were then reviewed and the positions when the heart rate changed were recorded down to the most inferior image of the heart. (As the equipment automatically displays the heart rate on the images, a new hb will result in a change in the displayed heart rate on the image obtained at that position.) The duration of each hb was calculated by dividing the D position (in mm) and table speed (in mm/s). This made it possible to calculate the number of hb needed to image the whole heart, the individual heart rate during scanning, and its variation.
The total number of hb faster than 80 and 100 hb/min was counted for each CM. The deviation in individual heart rate from the permitted heart rate range defi ned in the scan protocol (Table 1) was noted for each hb, and the mean absolute deviation was calculated for each CM.
Examples of calculation of heart rate deviation from the protocol Each hb has a duration. This means that each single hb also has a specifi c frequency, which can be expressed as number of hb per minute. Typically between four and fi ve hb are needed to image a heart. In a patient without an increase in heart rate, compared to prescanning, the frequency of those individual heart beats was 62, 61, 59, and 58 hb/min. This patient had been assigned to a protocol with the limits 58 -65, so there were no hb with a frequency outside the protocol. In another patient an increase in heart rate occurred at CM administration. The number of hb needed to image the heart in this patient was greater, i.e. six hb. The frequency of those individual heart beats was 63, 64, 65, 70, 61, and 62, respectively. One of those hb (number four) had a greater frequency (70 hb/min) than the upper limit (65 hb/min) allowed in the 58 -65 protocol.
VAS analysis
Immediately after scanning, patients fi lled in a questionnaire using the visual analog scale (VAS) regarding their experience of heat (19) . The scale was 100 mm long and ranged from " none " to " worst possible, " where no experience of heat was 0 mm and the worst possible heat sensation was 100 mm. The sensation experienced was marked using a pencil. The recorded sensations were measured using a plastic ruler.
Image quality assessment
The coronary arteries were divided into 18 segments, corresponding to those evaluated at invasive coronary angiography (ICA) (20) . The visualization of the segments was evaluated on a three-point scale (excellent, acceptable or not diagnostic) by two radiologists (J.R. and K.C, with 10 and 20 years of experience in radiology) in consensus. Occurrence of movement artifacts was noted for each segment.
Statistics
Differences between IOCM and LOCM were analyzed using Student ' s unpaired t test. Differences in total number of hb faster than 80 hb/min and 100 hb/min, the number of patients with changes in heart rate interfering with the scan protocol defi ned before scanning, the number of diagnostic segments, and the number of segments affected by movement artifacts were analyzed using Fischer ' s exact test. Difference in image quality was tested using the Mann -Whitney U test. The relationship between the deviation in heart rate from the individual mean heart rate in the selected protocol and the proportion of segments affected by movement artifacts was obtained by using linear regression analysis. P values Ͻ 0.05 were considered signifi cant.
Results
The average age in the IOCM group was 64 years (SD ϭ 8) and in the LOCM it was 63 years (SD ϭ 7). There were 31 men and 19 women in the IOCM group and 32 men and 18 women in the IOCM group. An average of 4.35 hb (SD ϭ 0.58) was needed to image the heart when using IOCM and 4.75 hb (SD 1.14) when using LOCM ( P Ͻ 0.05), giving a total number of hb of 184 for IOCM and 199 for LOCM. In total, 3 hb had a higher rate per minute than 80 after IOCM and 26 after LOCM ( P Ͻ 0.0001). Moreover, 1 hb after IOCM and 15 hb after LOCM had a higher rate than 100 ( P Ͻ 0.001). There was no statistically signifi cant (NS) difference in this study in average heart rate between IOCM and LOCM during scanning (59.6 vs 64.0). Nor was there any statistically signifi cant difference in mean heart (Table 2 ). There was no statistically signifi cant difference in the number of patients with changes in heart rate interfering with the scan protocol defi ned before scanning (31 vs 32). Questionnaires regarding heat sensation were obtained from 88 of the patients (45 after IOCM and 43 after LOCM). The LOCM group reported a stronger heat sensation after the CM injection than did the IOCM group (VAS ϭ 36 and 18 mm, respectively, P Ͻ 0.05, Table 2 ).
There was no statistically signifi cant difference in the number of diagnostic segments (492 vs 514), image quality (median score 1.79 vs 1.75) or number of segments affected by movement artifacts (167 vs 153) between the IOCM and LOCM group. There was a signifi cant relationship between the proportion of segments affected by movement artifacts and the deviation in heart rate from the selected protocol ( r ϭ 0.29, P Ͻ 0.01).
Discussion
The patients who did not deviate from the predicted heart rate had a signifi cantly lower total number of segments affected by movement artifacts compared with patients who deviated from the protocol. The mean deviation from the scanning protocol after LOCM administration was more than twice that of IOCM (4.7 hb/min vs 2.0 hb/ min), but the difference was not statistically signifi cant. This was probably due to great individual variation in the response to the CM, which is illustrated by the considerable difference in the standard deviation between the two CM (12.0 vs 4.1 hb/min). When evaluating the rate of individual hb, there was a signifi cantly higher total number of hb faster than both the 80 hb/min and 100 hb/min thresholds after LOCM than after IOCM (26 hb and 15 hb, respectively, of a total of 199 hb after LOCM, and 3 hb and 1 hb, respectively, of a total of 184 hb after IOCM, P Ͻ 0.001 for both). This indicates that there is a higher risk of arrhythmia during LOCM administration. No signifi cant difference was observed in the proportion of segments affected by artifacts between the two groups. Apparently, the individual variation in heart rate during scanning was greater than the differences in hemodynamic effects of the two CM.
A steady heart rate at a low frequency is the optimal situation at CTCA. The imaging window per hb is then long enough to acquire a sharp image, and the radiation modulation during the scanning can be optimal. If the heart rate at retrospective gating is different from the range defi ned in the exam protocol, increased radiation will occur at the wrong time point in the R-R interval. The images can still be reconstructed retrospectively at a correct time point, but image quality may be hampered due to radiation modulation. The vulnerability to changes in heart rate can theoretically be decreased by adjusting the dose modulation. This can be done by increasing the duration of the R-R time with full radiation exposure and/or increasing the radiation level during the remaining R-R period. These changes would, however, increase the total radiation exposure per examination and should therefore be avoided.
In a study using the same two CM as in our study in ICA, no difference was observed in hemodynamic changes (21). However, those measurements were made immediately before and after CM injection, whereas our measurements were made before and during CM injection. Furthermore, intravenous CM injections were investigated in the present study, whereas most other studies have investigated intra-arterial injections.
The heat sensation observed after IOCM administration was less than that observed after LOCM (VAS 18 mm compared with 36 mm, P Ͻ 0.05). Similar results were published by Manke et al. (22) . It has been suggested that the etiology of the heat sensation depends on high osmolality and a subsequent vasodilatation (23). This dilatation may cause a compensatory increase in heart rate to maintain the blood pressure. Some of the increase in heart rate might also result from the impact of psychological factors due to the experienced heat sensation.
It has previously been observed that different concentrations of the same non-ionic LOCM cause a difference in experienced heat sensation (19) . Most probably, the effects on heart rate and heat sensation observed in this study may, therefore, have been from a combination of both osmolarity and concentration.
The present study has certain limitations. When comparing the two types of CM, the same volume and injection technique was used. As they have different concentrations, the total dose of CM differed. It may be discussed whether the amount of IOCM (in ml/s) should have been increased to achieve the same concentration of iodine. However, the concentrations used in the present study are those commonly used for the respective CMs at CTCA (24 -27) . For this reason, a decrease in infusion speed and the total amount of IOCM would not be clinically relevant. When selecting the thresholds for evaluating arrhythmia, two levels were used, 80 hb/min and 100 hb/ min. These thresholds are subjective. Another limitation is the evaluation of image quality, which was made on a three-point scale. If a greater number of points had been used the probability of fi nding small differences in image quality might have been increased.
In conclusion, in clinically used concentrations the IOCM, iodixanol 320 mgI/ml, does not increase the heart rate during CTCA and causes less heart arrhythmia and less heat sensation than the LOCM, iomeprol 400 mgI/ml.
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